Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

Citation

  • Authors: Chen, H., Ma, F., Hu, X., Jin, T., Xiong, C., Teng, X.
  • Year: 2013
  • Journal: Biochem Biophys Res Commun 440 157-62
  • Applications: in vitro / siRNA / INTERFERin
  • Cell type: RAW 264.7
    Description: Mouse monocytes/macrophages
    Known as: RAW

Method

Final 5 nM siRNA was used and cells were analyzed 24h after the transfection.

Abstract

Increased systemic level of inflammatory cytokines leads to numerous age-related diseases. In senescent macrophages, elevated prostaglandin E2 (PGE2) production contributes to the suppression of T cell function with aging, which increases the susceptibility to infections. However, the regulation of these inflammatory cytokines and PGE2 with aging still remains unclear. We have verified that cyclooxygenase (COX)-2 expression and PGE2 production are higher in LPS-stimulated macrophages from old mice than that from young mice. Downregulation of RXRalpha, a nuclear receptor that can suppress NF-kappaB activity, mediates the elevation of COX2 expression and PGE2 production in senescent macrophages. We also have found less induction of ABCA1 and ABCG1 by RXRalpha agonist in senescent macrophages, which partially accounts for high risk of atherosclerosis in aged population. Systemic treatment with RXRalpha antagonist HX531 in young mice increases COX2, TNF-alpha, and IL-6 expression in splenocytes. Our study not only has outlined a mechanism of elevated NF-kappaB activity and PGE2 production in senescent macrophages, but also provides RXRalpha as a potential therapeutic target for treating the age-related diseases.

Go to